Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 August 2025 | Story Tshepo Tsotetsi | Photo Stephen Collett
Moot Court
The Law Clinic in the Faculty of Law at the University of the Free State (UFS) hosted the 20th annual Kovsie Moot Court Competition from 4 to 6 August 2025.

The Law Clinic in the Faculty of Law at the University of the Free State (UFS) recently hosted the 20th annual Kovsie Moot Court Competition, which brings together first-year law students from across Southern Africa. The competition took place from 4 to 6 August 2025 at the Supreme Court of Appeal (SCA) in Bloemfontein, offering students the rare opportunity to present arguments in one of the country’s highest courts.

Participating institutions included Eduvos (Bloemfontein Campus), the University of Johannesburg, Rhodes University, and the National University of Lesotho, among others. 

 

Moot Court as a culture and a foundation

Pinky Mokemane, Moot Court Coordinator at UFS, described the competition as far more than an event. “Moot Court is a culture. It brings to life everything students have been studying. They are not just reading theory – they are applying it, speaking it, and defending it,” she said.

Over 200 first-year LLB students signed up to participate in this year’s internal selection process, and three – Niniwe Rens, Kabelo Mokhotla, and Sfiso Mbasela – were ultimately selected to represent UFS. Mokemane said being able to argue legal points in the SCA is a privilege no other university currently offers, and students should not take this opportunity for granted.

Legal Behemoth, a UFS student association that works closely with the Law Clinic to promote a strong moot culture at the university, was a critical force behind the success of this year’s Moot Court programme. The group plays a central role in planning the competition – training students, liaising with legal professionals, and teaching foundational advocacy skills from scratch.

Lethabo Lekhuleng, Chairperson of Legal Behemoth, explained that the group’s support starts long before the competition itself. “We begin by training the students from the ground up. Most of them don’t know anything about oral advocacy or courtroom procedure. So we guide them, give direction, and help them build confidence step by step,” she said.

Describing the students’ growth over the course of the competition, she added, “It was definitely the confidence [that grew]. From the first round to the final round, they became far surer of themselves in how they spoke, how they presented arguments, and how they carried themselves in court.”

Herman du Randt, a senior associate at PH Attorneys and a UFS alumnus, was one of the judges presiding over the competition. “We were looking for confidence. A student must show that they trust themselves and know their arguments. It is not only what you say, but why you say it, and the legal authority behind it,” he explained. 

Du Randt was deeply impressed, describing the students’ overall performance as “breathtaking”. “The amount of effort they put in, the depth of their research, and the clarity of their arguments was exceptional,” he said.

He also emphasised the importance of such competitions in shaping the future of legal professionals. Drawing from his experience of representing UFS internationally through Moot Court, he said, “There are thousands of students graduating with LLBs every year. You need something that makes you stand out. Moot Court is one of the most exposure-rich things you can do as a student. If you don’t take part, you miss a huge opportunity.”

 

Growth through experience: voices from the court floor

Rens and Mokhotla spoke candidly about their experience. “It was hectic. There were sleepless nights, a lot of preparation. But it was all worth it,” Rens said. Both students want to become advocates, and for them, presenting arguments in the SCA was a glimpse into their future.

Mokhotla reflected on what the experience taught her about herself: “I am not defined by failure. The fact that I stood in that court and saw my name there already meant so much. It was nerve-wracking, but I pushed myself to the limit – and that’s what I’ll take with me.”

Christopher Rawson, Acting Director of the UFS Legal Clinic, placed this year’s Moot Court effort within a broader educational vision. “The UFS Law Clinic plays a unique role in integrating practical legal education into the formal curriculum. The clinic hosts the competition and facilitates access to real-world and professionally relevant experiences in a court that is steeped in constitutional history, intellectual rigour, and the pursuit of justice. By doing so, the competition also supports the UFS’s Vision 130 commitments to producing graduates who are socially engaged, ethically grounded, and professionally competent,” he said.

Rawson also noted that early exposure to legal reasoning and oral argument builds the analytical and ethical foundation that students need. “From their initial submissions to their final oral arguments, the growth shown by our students reflects the strength of our approach – combining academic knowledge with skills-based learning and mentorship.”

Through its 20th edition, the Kovsie Moot Court Competition once again demonstrated that legal education at UFS is not confined to lecture halls. 

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept